Social gradient predicts survival disadvantage of African Americans/Black children with lymphoma

Laurens Holmes1, Malik A Williams2, Daniel R Halloran1

  • 1Nemours Children's Healthcare System-Translation Health Disparities Science Research, Wilmington, DE, United States; Biological Sciences Department, University of Delaware, Newark, DE, United States.

Insights

Black children with lymphoma face higher mortality and survival disadvantages compared to white children. Socioeconomic factors like urbanity and income contribute to these disparities, highlighting the need for environmental improvements.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Health Disparities

Background:

  • Childhood cancer, particularly lymphoma, is a leading cause of mortality in children.
  • Lymphoma affects lymphoid cells, including B and T cells, and is common in pediatric populations.
  • Understanding cumulative incidence, mortality, and survival is crucial for pediatric lymphoma management.

Purpose of the Study:

  • To assess the cumulative incidence (CmI) of pediatric lymphoma.
  • To evaluate mortality rates and survival outcomes in children diagnosed with lymphoma.
  • To investigate the influence of social determinants of health on pediatric lymphoma outcomes.

Main Methods:

  • Retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) data.
  • Inclusion of children aged 0-19 years diagnosed with lymphoma.
  • Analysis of social determinants including urbanity, median household income, and race, using chi-square, binomial regression, and Cox proportional hazard models.

Main Results:

  • Cumulative incidence was highest among white children (76.67%) compared to other racial groups.
  • Black/African American (AA) children experienced excess mortality (RR=1.54) and a higher likelihood of death (HR=1.52) compared to white children.
  • A survival disadvantage persisted among Black/AA children even after adjusting for confounders (aHR=1.54).

Conclusions:

  • Black/AA children with lymphoma exhibit a significant survival disadvantage relative to white children.
  • Urbanity and median household income were identified as factors contributing to racial differences in survival.
  • Addressing environmental and socioeconomic factors is essential to reduce racial disparities in pediatric lymphoma survival.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
508
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
388
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K